Trial intelligence / Profile preview

High-dose safety study of TK61406 in healthy adults

jRCT1091220206Completed

Sponsor
Tokai Pickling
Start
Jan 2015
Modality
Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Countries
1
01

Overview

Open-label, single-arm trial of TK61406, sponsored by Tokai Pickling. Started Jan 2015; status: completed.

02

Drugs

TK61406

Beyond the preview

Go deeper on jRCT1091220206.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1091220206.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call